Among the products previewed in the BiOS 2011 exhibits was Oxxius’s 588 nm laser, which provides up to 50 mW of power. This is an upcoming addition to the company’s LaserBoxx laser diode product line that offers wavelengths from the ultraviolet (375 nm) all the way up to 785 nm, and is targeted to biotechnology applications.
Oxxius said that its SLIM DPSS laser line (already released) was getting a lot of attention from BiOS attendees; in particular, the 553 nm wavelength model, with up to 200 mW of power, which the company says is unique in the market. The SLIM light sources are offered in various versions: a plug-and-play version, an OEM version (for system integration), a CDRH-compliant version (for academic users), and "low noise" and "single longitudinal mode" versions.
Showing posts with label BiOS 2011. Show all posts
Showing posts with label BiOS 2011. Show all posts
Monday, March 14, 2011
Monday, February 14, 2011
Previewed at BiOS ’11--Part 1
During BiOS/Photonics West 2011, I got to see a number of newly released products (see recent new product postings and stay tuned for later blog entries)--and to preview products not yet available.
During BiOS/Photonics West 2011, I got to see a number of newly released products (see recent new product postings and stay tuned for later blog entries)--and to preview products not yet available.
For instance, I learned about the latest version of Imagine Eyes’s rtx1 Adaptive Optics Retinal Camera, for which they had just received the first orders. The first device of its kind as far as I know, it features automated adaptive optics and captures en face cellular-level images of the retina in vivo without pupil dilation. It reportedly can discern things that optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) cannot, and produces 1200 x 1200 micron images that can be tiled together to view larger areas. Imagine Eyes is now marketing to researchers, and expects FDA approval in about a year. Meantime the company is building a morphological image database and gathering feedback from clinical partners including France’s national ophthalmic center.
During BiOS/Photonics West 2011, I got to see a number of newly released products (see recent new product postings and stay tuned for later blog entries)--and to preview products not yet available.
For instance, I learned about the latest version of Imagine Eyes’s rtx1 Adaptive Optics Retinal Camera, for which they had just received the first orders. The first device of its kind as far as I know, it features automated adaptive optics and captures en face cellular-level images of the retina in vivo without pupil dilation. It reportedly can discern things that optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO) cannot, and produces 1200 x 1200 micron images that can be tiled together to view larger areas. Imagine Eyes is now marketing to researchers, and expects FDA approval in about a year. Meantime the company is building a morphological image database and gathering feedback from clinical partners including France’s national ophthalmic center.
Tuesday, January 18, 2011
Gearing up for Biomedical Optics Symposium (BiOS)/Photonics West--Part 1
This weekend I'll be attending the Biomedical Optics Symposium (BiOS), which now represents 45% of the educational content at Photonics West. Saturday night will find me at the appropriately named Hot Topics plenary, which promises to deliver "the latest technical breakthroughs and directions from leading worldwide experts.” Each year, this plenary showcases some of the most interesting work underway—mostly in research, but also in the commercial realm.
This weekend I'll be attending the Biomedical Optics Symposium (BiOS), which now represents 45% of the educational content at Photonics West. Saturday night will find me at the appropriately named Hot Topics plenary, which promises to deliver "the latest technical breakthroughs and directions from leading worldwide experts.” Each year, this plenary showcases some of the most interesting work underway—mostly in research, but also in the commercial realm.
This year’s Hot Topics will begin with a tribute to Michael Feld, the MIT professor who pioneered the application of spectroscopy to biomedicine. Not long after BiOS 2010, Feld lost his battle with cancer, but his presence is still with us, as will be demonstrated in a discussion of recent work that promises to overcome obstacles to the long-anticipated promise of noninvasive glucose monitoring and tomographic cell imaging.
This weekend I'll be attending the Biomedical Optics Symposium (BiOS), which now represents 45% of the educational content at Photonics West. Saturday night will find me at the appropriately named Hot Topics plenary, which promises to deliver "the latest technical breakthroughs and directions from leading worldwide experts.” Each year, this plenary showcases some of the most interesting work underway—mostly in research, but also in the commercial realm.
This year’s Hot Topics will begin with a tribute to Michael Feld, the MIT professor who pioneered the application of spectroscopy to biomedicine. Not long after BiOS 2010, Feld lost his battle with cancer, but his presence is still with us, as will be demonstrated in a discussion of recent work that promises to overcome obstacles to the long-anticipated promise of noninvasive glucose monitoring and tomographic cell imaging.
Subscribe to:
Posts (Atom)